BTSGBTSGHealthcare · Health Information Services

BTSG Stock Forecast: BrightSpring Health Services, Inc. Price Predictions for 2026-2027

Last close, 24 Aug 2026
$59
+1.06% on the day

The 18 Wall Street analysts covering BrightSpring Health Services, Inc. hold a median 12-month price target of $80 — +34.5% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 91 of 100 as at 22 Aug 2026 — among the strongest tenth. Here, the model and the Street point the same way.

Market cap
$11.8B
Ticker Nerd rank
91 / 100
Median analyst target
$80
Analysts covering
18
Revenue$3.9B+23.0% y/y
Operating income$130.4M
Net income$84.2M
Free cash flow$14.9M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−1.5%
1M
−18.4%
YTD
+58.9%
1Y
+139.2%
From 52W high
−18.4%
From 52W low
+151.1%
$24
$73
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

BTSG stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores BrightSpring Health Services, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 22 Aug 2026
91 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Momentum
95
Revisions
93
Growth
82
Accruals
76
Issuance
71
Quality
58
Value
54
Volatility
46
Size
15

Momentum (95): The shares have been drifting up relative to others.

Volatility (46): The share price moves around a lot.

Size (15): Larger than most of the companies we track — more scrutinised, less often mispriced.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

BTSG stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on BTSG, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$20$40$60$80$100Oct 25Jan 26Apr 26Jul 26BTSGHigh $90Median $80Low $70

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says18 analysts
18 Buy0 Hold0 Sell
Low $70Median $80High $90

The green dot is the last close — the median target sits +34.5% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 4 moved their price target up and 0 moved it down.

DateFirmActionRatingTarget
13 Aug 2026BTIGReiteratesBuy$90
3 Aug 2026BTIGReiteratesBuy$90
3 Aug 2026BTIGReiteratesBuy
14 July 2026KeybancMaintainsOverweight
14 July 2026KeybancMaintainsOverweight$60$80
14 July 2026Morgan StanleyMaintainsOverweight$71$80
14 July 2026Morgan StanleyMaintainsOverweight
13 July 2026GuggenheimInitiatesBuy
13 July 2026GuggenheimInitiatesBuy$81
13 July 2026Wells FargoMaintainsOverweight
13 July 2026Wells FargoMaintainsOverweight$61$78
10 July 2026Raymond JamesInitiatesOutperform$80
10 July 2026Raymond JamesInitiatesOutperform
8 July 2026UBSMaintainsBuy
8 July 2026UBSMaintainsBuy$63$85
2 July 2026B of A SecuritiesMaintainsBuy
22 June 2026BTIGMaintainsBuy
18 June 2026TD CowenMaintainsBuy
8 June 2026Goldman SachsInitiatesBuy
2 June 2026Morgan StanleyMaintainsOverweight

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. BTSG appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

BTSG vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 24 Aug 2026, BrightSpring Health Services, Inc. returned +139.2% against +19.6% for the S&P 500, dividends included.

BTSG vs S&P 500, last 12 monthsTotal return, rebased to 100
100150200250300Oct 25Jan 26Apr 26Jul 26BTSGS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

BTSG analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
+8.4%
Analysts raising
14
Analysts cutting
0
Fundamentals

BrightSpring Health Services, Inc. (BTSG) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
53.1×

Cheaper than 14% of US stocks

Price / sales
0.8×

Cheaper than 74% of US stocks

Price / book
6.0×

Cheaper than 18% of US stocks

EV / EBITDA
22.5×

Cheaper than 14% of US stocks

Growth & margins
Revenue growth (YoY)
23.0%

Higher than 73% of US stocks

Earnings growth (YoY)
198.8%

Higher than 90% of US stocks

Gross margin
12.7%

Higher than 12% of US stocks

Operating margin
3.4%

Higher than 51% of US stocks

Net margin
2.5%

Higher than 53% of US stocks

Returns & dividend
Return on equity
13.0%

Higher than 71% of US stocks

Return on assets
4.9%

Higher than 75% of US stocks

Dividend yield

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

BrightSpring Health Services, Inc. (BTSG) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • BrightSpring Health Services, Inc. has a market value of $11.8B and an enterprise value of $14.1B.

  • Revenue in the twelve months to 30 June 2026: $14.4B. The latest quarter grew 23.0% year on year.

  • Net income over the same four quarters: $365.4M, a 2.5% net margin.

  • Diluted earnings per share, trailing twelve months: $1.66.

  • Free cash flow in the twelve months to 30 June 2026: $402.4M.

  • BrightSpring Health Services, Inc. spent $163.2M on share buybacks in the twelve months to 30 June 2026.

  • Shares outstanding: 197.5M.

  • Trailing P/E: 53.1×; forward P/E: 26.1× — the forward figure prices analyst consensus estimates, not reported earnings.

  • BrightSpring Health Services, Inc. employs 23,500 people $612K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 25 Aug 2026

Data provided by Twelve Data

Peers

BTSG vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelHealth Information Services
CompanyMarket capTKN rank
BTSGBrightSpring Health Services, Inc.$11.8B
91
TEMTempus AI, Inc.$13.0B
25
HQYHealthEquity, Inc.$9.0B
95
TXG10X Genomics, Inc.$8.1B
94
HNGEHinge Health, Inc.$6.8B
82
WAYWaystar Holding Corp.$4.8B
34
DOCSDoximity, Inc.$4.7B
61

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own BrightSpring Health Services, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest BTSG news & analysis

Sandisk & 2 Profitable Stocks to Buy Now for Explosive Upside

Zacks Investment Research · 24 Aug 2026positive

Zacks Investment Research highlighted BrightSpring among profitable stocks, noting strong net income ratios and earnings growth support upside potential.

Why it matters — The report positions BTSG as a profitable company with solid earnings, which may draw attention from investors following the stock.

3 Medical Service Stocks Resilient Amid Persistent Workforce Shortage

Zacks Investment Research · 24 Aug 2026positive

Zacks Investment Research highlighted BrightSpring Health Services alongside CareDx and PACS Group as one of three medical service stocks positioned for growth. The report cited expanding digital health and workforce shortages reshaping the medical services landscape as contributing factors.

Why it matters — The item highlights BrightSpring among select medical service companies expected to benefit from ongoing workforce shortages and digital health expansion in the sector.

3 Non-Tech Thriving Nasdaq Stocks Enabling Its Northward Move in 2026

Zacks Investment Research · 24 Aug 2026positive

BrightSpring Health Services (BTSG) is identified by Zacks Research as one of three non-tech Nasdaq stocks thriving in 2026, alongside Interactive Brokers and Roku. BTSG's performance is attributed to growth in care migration supporting its broader business momentum.

Why it matters — The article highlights BTSG as a thriving Nasdaq name, indicating positive recognition of its performance amid care migration-driven growth.

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet

Benzinga · 22 Aug 2026neutral

Benzinga's weekly "Stock Whisper Index" uses proprietary data and pattern recognition to highlight five stocks that are just under the surface and deserve attention. BrightSpring Health Services appears to be one of the stocks featured in this list.

Why it matters — BTSG watchers would care because the index highlights stocks that are gaining attention but not yet widely discussed, suggesting increased investor monitoring of the company.

BrightSpring Stock Up Nearly 59% YTD: Can Its Growth Story Continue?

Zacks Investment Research · 21 Aug 2026positive

BrightSpring Health Services (BTSG) shares have risen nearly 59% year-to-date, a gain attributed to 23% revenue growth, rising margins, and expansion in specialty pharmacy and home-based care, according to Zacks Investment Research.

Why it matters — The company's strong YTD stock performance and underlying revenue/margin growth highlight the momentum in its specialty pharmacy and home-based care segments that BTSG watchers would track.

FAQ

Frequently asked questions about BTSG stock

What is the BTSG stock price forecast for 2026-2027?

The 18 Wall Street analysts covering BrightSpring Health Services, Inc. have a median 12-month price target of $80, with estimates ranging from $70 to $90. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is BTSG stock a buy right now?

Of the 18 analysts covering BrightSpring Health Services, Inc., 18 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks BrightSpring Health Services, Inc. 91 out of 100 across roughly 4,600 US stocks as at 22 Aug 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank BTSG?

As at 22 Aug 2026, BrightSpring Health Services, Inc. ranks 91 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Momentum (95 of 100).

Will BTSG stock go up?

No one can know that. What the data says: the median 12-month target from 18 analysts implies +34.5% from the last close, and Ticker Nerd's factor model ranks BrightSpring Health Services, Inc. 91 out of 100 as at 22 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the BTSG stock forecast for 2030?

No analyst covering BrightSpring Health Services, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for BTSG are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $70 to $90 over the next 12 months.

How has BTSG stock performed over the past year?

BrightSpring Health Services, Inc. returned +139.2% over the 12 months to 24 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does BrightSpring Health Services, Inc. do?

BrightSpring Health Services, Inc. is a leading provider of comprehensive home- and community-based health services for complex populations requiring specialized and chronic care.

What is the latest news on BTSG?

The most recent item we track (Zacks Investment Research, 24 Aug 2026): "Sandisk & 2 Profitable Stocks to Buy Now for Explosive Upside". Zacks Investment Research highlighted BrightSpring among profitable stocks, noting strong net income ratios and earnings growth support upside potential.

Company

About BrightSpring Health Services, Inc.

BrightSpring Health Services, Inc. is a leading provider of comprehensive home- and community-based health services for complex populations requiring specialized and chronic care. The company delivers integrated pharmacy and provider services, including supportive care, clinical solutions, home health care, hospice, behavioral and neuro rehabilitation, and pharmacy therapy management across various settings. It serves high-need patients, such as seniors, individuals with disabilities, and those under Medicare, Medicaid, or insured programs, emphasizing quality outcomes through best-in-class services and advanced technology. Notable features include electronic health record solutions like TaskMaster Pro and QuickMAR, data analytics, telehealth, smart home monitoring, and care management platforms that enable high-tech, high-touch care. BrightSpring Health Services, Inc. focuses on connecting people with caregivers to enhance well-being in home and community environments nationwide. Founded in 1974 and headquartered in Louisville, Kentucky, it plays a vital role in the healthcare sector by supporting medically complex individuals through innovative, patient-centered approaches.

CEO Mr. Jon B. Rousseau · 23,500 employees · United States · https://www.brightspringhealth.com